Although it is important to examine quantitative aspects, such as the frequencies of TAA tetramer positive CD8+T cells, the cytotoxicity of these T cells against cancer cells that express the TAA peptide endogenously cannot be confirmed. The gene discussed is CD8A; the disease is cancer.